Seoul National University (SNU) Bundang Hospital Biomedical Research Institute has concluded a Memorandum of Understandi...
The global biopharma company GSK plc has launched a new, S$44 million high potency facility (HPF) in its strategic New P...
Australian startup BiomeBank has announced the first regulatory approval for a donor derived microbiome drug product wor...
A new University of Auckland spin-out company, TheiaNova, is working to introduce a groundbreaking, non-invasive treatme...
Founded in 2015 by Koji Tanabe, a graduate of Professor Shinya Yamanaka's laboratory at Kyoto Univer...
A world-first clinical trial platform launching in Melbourne is set to transform research into new therapies for brain c...
How would you describe your primary mission and vision of the Centre for Microbiome Medicine? Microbiome is the l...
JW Therapeutics and 2seventy bio have announced a strategic alliance to establish a translational and clinical cell ther...
The winner of this year's pre-eminent research award in the Faculty of Medical and Health Sciences, Professor Michael (M...
Nanyang Technological University (NTU) Singapore scientists have found that a stress response in cells, when ‘swit...
PT Etana Biotechnologies Indonesia (Etana) on 7 October, 2022, inaugurated a biopharmaceutical factory located...
South Korean chemical company LG Chem has announced a definitive agreement with AVEO Oncology in which LG Chem will...
An immunity research study has found that the previously identified disease-associated microglia (DAM) population d...
The Australian government is providing almost $700,000 to fund new research investigating the impact of endometriosis on...
According to International Diabetes Federation, approximately 537 million adults (20-79 years) are living with diabetes ...
Australia based AdAlta Limited, the clinical stage drug discovery company and South Korea based GPCR Therapeutics Inc, a...
A new study conducted by The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) has discov...
The most common form of solid tumour affecting children is neuroblastoma. It is known to be the cause of a disproportion...
